Parenting Concerns in Patients With Cystic Fibrosis (MucoPar)
NCT ID: NCT04133246
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2019-09-25
2020-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The collected information should make it possible to develop and propose adapted medico-psycho-social interventions, if necessary, in connection with patient associations
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Concerns of Children Whose Parents Have Cystic Fibrosis
NCT04702386
Psychological Study in Children With Mucoviscidosis
NCT05948488
Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic
NCT04463628
Health Outcomes of Parents With Cystic Fibrosis
NCT05829694
A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring
NCT06797206
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, the purpose of this study is to explore and collect the perceptions, expectations and needs of CF patients and their spouses about parenting.
All patients with children, followed in 2 large adult CF centers, and their spouses will be invited to participate in a 6 to 10-person discussion group (focus group) led by a psychologist. He will ensure that all the participants express themselves and are encouraged to develop their points of view, their divergences and their common points about what constitutes to be a parent. The discussions will be recorded and transcribed.
Patients who cannot participate in groups (e.g. patients colonized with Burkholderia cepacia complex) but wish to be included in the study will benefit from an individual interview with the psychologist, also registered and transcribed. A thematic analysis will be carried out from the transcriptions of group contents. For individual interviews, phenomenological interpretative analysis (IPA) will be used. A synthesis of the two analyses will then be done.
The collected information should make it possible to develop and propose adapted medico-psycho-social interventions, if necessary, in connection with patient associations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group arm
Includes subjects enrolled in focus groups
Focus group
Groups of 6 to 10 patients and spouses led by the psychologist about their parenthood lasting 2 hours
Interview arm
Includes subjects with individual interviews
Individual interview
Interview led by the psychologist about the patient's parenthood
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focus group
Groups of 6 to 10 patients and spouses led by the psychologist about their parenthood lasting 2 hours
Individual interview
Interview led by the psychologist about the patient's parenthood
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have cystic fibrosis
* Be a parent and raise or have raised at least one child
* Being followed in one of the two adult CF centers participating in the study
For CF patients' spouses
\- Live with the CF patient participating in the study
For both CF patients and spouses
* Being an adult (at least 18 y.o.)
* Have a good level of French and good speaking skills
Exclusion Criteria
* Psychiatric pathology (borderline state, bipolarity and other psychotic disorders)
* Serious somatic disease not related to cystic fibrosis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cécile FLAHAULT, Ph.D
Role: STUDY_CHAIR
Assistance Publique - Hôpitaux de Paris
Dominique HUBERT, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cochin Hospital
Paris, Île-de-France Region, France
Foch Hospital
Suresnes, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jacob A, Hubert D, Brain C, Grenet D, Flahault C. Exploring the lived experiences of parents living with cystic fibrosis: A qualitative study. J Health Psychol. 2025 Aug;30(9):2183-2200. doi: 10.1177/13591053241307874. Epub 2025 Jan 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A03241-54
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.